Top trader Najarian, up 10% YTD, buys biotech


CNBC "Halftime Report" trader Jon Najarian bought shares of AbbVie for his model portfolio in CNBC Pro's trading competition. Najarian's portfolio is up 10 percent year-to-date.

In other moves, Najarian sold Synchrony Financial and First Solar.

Read below to find out why Najarian is bullish on the biotech company.

More In Pro News and Analysis

CNBC ProWall Street likes these infrastructure stocks a lot as Washington gets set to give sector a boost
CNBC ProCathie Wood's ARK funds bought $65 million more of Robinhood stock
CNBC ProGoldman says buy these quality stocks as Fed uncertainty potentially roils markets